KBC Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40K | Sell |
2,313
-1,537
| -40% | -$26.6K | ﹤0.01% | 1665 |
|
|
2025
Q1 | $84K | Sell |
3,850
-100,437
| -96% | -$2.19M | ﹤0.01% | 1581 |
|
|
2024
Q4 | $3.33M | Buy |
104,287
+101,655
| +3,862% | +$3.24M | 0.01% | 576 |
|
|
2024
Q3 | $76K | Buy |
2,632
+679
| +35% | +$19.6K | ﹤0.01% | 1467 |
|
|
2024
Q2 | $75K | Buy |
1,953
+356
| +22% | +$13.7K | ﹤0.01% | 1352 |
|
|
2024
Q1 | $94K | Sell |
1,597
-25
| -2% | -$1.47K | ﹤0.01% | 1154 |
|
|
2023
Q4 | $97K | Hold |
1,622
| – | – | ﹤0.01% | 1078 |
|
|
2023
Q3 | $62K | Buy |
+1,622
| New | +$62K | ﹤0.01% | 1276 |
|